NBO Pharma See The Immediate Benefits of An Integrated Approach to Intranasal Product Development with The Aptar Pharma Family of Services

Dry powder inhaler, Nanopharm, OINDPs

17 Aug 2026

NBO Pharma See The Immediate Benefits of An Integrated Approach to Intranasal Product Development with The Aptar Pharma Family of Services

Articles

ISAM 2026: Looking Forward to the Next Chapter for Inhaled and Nasal Drug Delivery

Key takeaways from ISAM 2026: Nanopharm’s Lucas Silva on inhaled biologics, digital health and regulatory science in nasal and pulmonary drug delivery.

August 18, 2026 No Comments

Articles

Balancing Creativity with Compliance: Meet Kirsten Searle, Manager of Pharma Development

Discover how Kirsten Searle is enhancing project management excellence at Nanopharm. Hear about her philosophy on balancing pragmatic process with scientific innovation in a fast-paced CRO environment.

July 6, 2026 No Comments

Articles

Inhaled Generic Bioequivalence Modeling Approaches

Learn how advanced in vitro and in silico modeling help generics companies overcome complex bioequivalence hurdles for orally inhaled drug products (OIDPs).

July 6, 2026 No Comments

About Us

Product Development

Analytical Services

In-Silico Modeling

Regulatory

Nasal

Inhalation

Inhaled Biologics

Generics & Lifecycle Management

Resources

17 Aug 2026

NBO Pharma See The Immediate Benefits of An Integrated Approach to Intranasal Product Development with The Aptar Pharma Family of Services

Related Posts

ISAM 2026: Looking Forward to the Next Chapter for Inhaled and Nasal Drug Delivery

Balancing Creativity with Compliance: Meet Kirsten Searle, Manager of Pharma Development

Inhaled Generic Bioequivalence Modeling Approaches